Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Cardiac Resynchronization Therapy With or Without Defibrillation: A Long-Standing Debate.
Golzio PG, Bocchino PP, Bissolino A, Angelini F, Gravinese C, Frea S.
Cardiol Rev. 2022 Sep-Oct 01;30(5):221-233. doi: 10.1097/CRD.0000000000000388. Epub 2021 Mar 19.
Socio-economic analysis of cardiac resynchronization therapy.
Field ME, Sweeney MO.
J Interv Card Electrophysiol. 2006 Dec;17(3):225-36. doi: 10.1007/s10840-006-9079-4. Epub 2007 Mar 20.
Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death.
Zhu DWX, Chu MM, House CM.
Europace. 2017 Dec 1;19(12):2007-2014. doi: 10.1093/europace/euw311.
Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting.
Nakou ES, Simantirakis EN, Kallergis EM, Nakos KS, Vardas PE.
Europace. 2017 May 1;19(5):705-711. doi: 10.1093/europace/euw317.
Mid-term feasibility and safety of downgrade procedure from defibrillator to pacemaker with cardiac resynchronization therapy.
Ogano M, Iwasaki YK, Tsuboi I, Kawanaka H, Tajiri M, Takagi H, Tanabe J, Shimizu W.
Int J Cardiol Heart Vasc. 2018 Dec 29;22:78-81. doi: 10.1016/j.ijcha.2018.12.012. eCollection 2019 Mar.
Cardiac resynchronization therapy improves myocardial conduction.
Yang M, Li X, Yang D, Li Y, Zhou S, Liang J, Wu G, Del-Carpio Munoz F, Chen HH, Friedman PA, Cha YM.
Pacing Clin Electrophysiol. 2019 Feb;42(2):238-246. doi: 10.1111/pace.13581. Epub 2018 Dec 27.
First Demonstration of Cardiac Resynchronization Therapy Defibrillator Service Life Exceeding Patient Survival in a Heart Failure with Reduced Ejection Fraction Cohort.
Williams JL, Harley B, Williams G.
J Innov Card Rhythm Manag. 2020 Dec 15;11(12):4325-4332. doi: 10.19102/icrm.2020.111203. eCollection 2020 Dec.
Predictors and outcomes of cardiac resynchronization therapy extended to the second generator.
Li X, Yang D, Kusumoto F, Shen WK, Mulpuru S, Zhou S, Liang J, Wu G, Yang M, Liu JQ, Friedman PA, Cha YM.
Heart Rhythm. 2017 Dec;14(12):1793-1800. doi: 10.1016/j.hrthm.2017.09.002. Epub 2017 Sep 14.
Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
Tilz R, Boveda S, Deharo JC, Dobreanu D, Haugaa KH, Dagres N.
Europace. 2016 Jun;18(6):945-9. doi: 10.1093/europace/euw157.
Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
Boriani G, Merino J, Wright DJ, Gadler F, Schaer B, Landolina M.
Europace. 2018 Dec 1;20(12):1882-1897. doi: 10.1093/europace/euy066.
